Newsroom

BASEL, Switzerland--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced the appointment of Peter Bodlund as President and Chief Executive Officer, effective April 1, 2026. He succeeds Koichiro Sato, who will continue in his roles as Chief Operating Officer of PHC Group and Head of PHC Group’s Diabetes Management business. Peter has held senior leadership roles across global healthcare and life sciences o...

BERLIN--(BUSINESS WIRE)--The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficie...

LONDON--(BUSINESS WIRE)--  ISIN Code. XS2448367800 Our Ref. MO4624 ISSUE NAME. Commonwealth Bank of Australia Issue of AUD 13,000,000.00 Floating Rate Notes due 24 February 2032 Series no 6455 Tranche 1 MTN INTEREST PERIOD. 24/02/2026 TO 26/05/2026 VALUE DATE. 26/05/2026 INTEREST RATE. 4.8875 PCT NUM OF DAYS. 91 DAY BASIS. ACTUAL/365 FIXED (A005) CURRENCY CODE. AUD TOTAL INTEREST AMT. AUD 158,408.56 POOL FACTOR. N/A...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 24 February 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 24 February 2026 Number of Public Shares Purchased:...

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted i...

LONDON--(BUSINESS WIRE)--  25 February 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 24 February 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Stifel Nicolaus Europe...

LONDON--(BUSINESS WIRE)--  ISIN Code. XS2526496117 Our Ref. MO9122 ISSUE NAME. City of Stockholm Issue of NOK 3,000,000,000.00 Floating Rate Notes Due Aug 2027 Series No EMTN 91 Tranche 1 MTN INTEREST PERIOD. 26/02/2026 TO 26/05/2026 VALUE DATE. 26/05/2026 INTEREST RATE. 4.68 PCT NUM OF DAYS. 89 DAY BASIS. Actual/360 (A004) CURRENCY CODE. NOK TOTAL INTEREST AMT. NOK 34,710,000 POOL FACTOR. N/A...

BOSTON--(BUSINESS WIRE)--PureTech to Present at the Leerink Partners Global Healthcare Conference...

AMSTERDAM--(BUSINESS WIRE)--AM Best is revising its outlook for Germany’s life insurance segment to stable from negative. In its new Best’s Market Segment Report, “Market Segment Outlook: Germany Life Insurance”, AM Best states that the revision of its outlook primarily reflects the stabilisation of key trends for the segment in the current positive interest rate environment. In addition, AM Best notes that life insurance premium income is expected to remain resilient over the next 12 months, d...

ECULLY, France--(BUSINESS WIRE)--Regulatory News: GROUPE SEB (Paris:SK): Déclaration de Stanislas de Gramont, Directeur Général du Groupe SEB : « Dans un environnement resté complexe, le Groupe SEB enregistre en 2025 une légère croissance organique de ses ventes, mais un repli marqué de sa rentabilité, reflet d’un exercice difficile. La solidité de notre innovation, les bonnes dynamiques en entretien des sols, soin du linge et articles culinaires, ainsi que la croissance soutenue de nos ventes...